Notice of Intent to Sole Source for Single Donor, Type Specific, Universal Freeze-Dried Plasma Activities for Commercial Sustainability

Special NoticeNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in FORT DETRICK, MD
  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Contract Details

Notice ID
HT942726RE014
Opportunity Type
Special Notice
Sub-Agency
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY
Posted Date
Thursday, June 4, 2026
Response Deadline
Monday, June 22, 2026
PSC Code
AN13
Set-Aside
No Set Aside
Place of Performance
FORT DETRICK, MD, 21702
Status
Active

Description

This is a Notice of Intent (NOI) to Sole Source on the basis of other than full and open competition. This is not a Request for Quotes or Proposals. The purpose of this notice is to allow interested parties to assert and explain their capability to satisfy the requirement described. The Defense Health Agency Contracting Activity (DHACA) Medical Research & Development Contracting Division 2, in support of the Defense Health Agency (DHA) Portfolio Acquisition Executive (PAE) Medical Products, intends to execute a contract on a sole source basis under the authority of the Revolutionary FAR Overhaul (RFO) FAR 6.103-1 to Vascular Solutions LLC, 6464 Sycamore CT N, Maple Grove, Minnesota, 55369-6032 (a subsidiary of Teleflex LLC), which will develop, license, and sustain a Freeze-Dried Plasma (F

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) with a set-aside for No Set Aside businesses in FORT DETRICK, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.